200 related articles for article (PubMed ID: 12324815)
41. Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt.
Cervera M; Añón R; Palmero J; Martínez J; Garcés R; Ripollés T; Moreno-Osset E; Alamán G; Antón M
Rev Esp Enferm Dig; 2000 Apr; 92(4):199-210. PubMed ID: 10867409
[TBL] [Abstract][Full Text] [Related]
42. Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients.
Turnes J; García-Pagán JC; González-Abraldes J; Real M; Moitinho E; Gilabert R; Escorsell A; Muntanya X; Ginès P; Bosch J; Rodés J
Liver Transpl; 2001 Jul; 7(7):649-51. PubMed ID: 11460235
[TBL] [Abstract][Full Text] [Related]
43. Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure.
Thalheimer U; Triantos C; Samonakis D; Patch D; Burroughs AK
Scand J Gastroenterol; 2009; 44(12):1463-70. PubMed ID: 19958060
[TBL] [Abstract][Full Text] [Related]
44. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
[TBL] [Abstract][Full Text] [Related]
45. Transjugular intrahepatic portosystemic shunts (TIPS): a decade later.
Ong JP; Sands M; Younossi ZM
J Clin Gastroenterol; 2000 Jan; 30(1):14-28. PubMed ID: 10636206
[TBL] [Abstract][Full Text] [Related]
46. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
47. TIPS: 25 years later.
Rössle M
J Hepatol; 2013 Nov; 59(5):1081-93. PubMed ID: 23811307
[TBL] [Abstract][Full Text] [Related]
48. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.
Tripathi D; Redhead D
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1127-33. PubMed ID: 17033430
[TBL] [Abstract][Full Text] [Related]
49. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
[TBL] [Abstract][Full Text] [Related]
50. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
51. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
Olliff SP
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
[TBL] [Abstract][Full Text] [Related]
52. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
Papp M; Mezei G; Udvardy M; Altorjay I
Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
[TBL] [Abstract][Full Text] [Related]
53. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
Kavanagh PM; Roberts J; Gibney R; Malone D; Hegarty J; McCormick PA
J Gastroenterol Hepatol; 2004 Oct; 19(10):1135-9. PubMed ID: 15377290
[TBL] [Abstract][Full Text] [Related]
54. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures.
Qi X; Yang M; Fan D; Han G
Scand J Gastroenterol; 2013 Jul; 48(7):771-84. PubMed ID: 23506234
[TBL] [Abstract][Full Text] [Related]
55. [Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites].
Rovira E; Molés JR; Hinojosa J; Primo J; Gonzalvo F; Albert A
Rev Esp Enferm Dig; 1997 Jun; 89(6):475-7. PubMed ID: 9303612
[TBL] [Abstract][Full Text] [Related]
56. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
Attwell A; Ludkowski M; Nash R; Kugelmas M
Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
[TBL] [Abstract][Full Text] [Related]
57. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
Kim JJ; Dasika NL; Yu E; Fontana RJ
J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
[TBL] [Abstract][Full Text] [Related]
58. [Current ascites therapy].
Ochs A
Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
[TBL] [Abstract][Full Text] [Related]
59. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
Masson S; Mardini HA; Rose JD; Record CO
QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
[TBL] [Abstract][Full Text] [Related]
60. Torulopsis glabrata fungemia from infected transjugular intrahepatic portosystemic shunt stent.
Brickey TW; Trotter JF; Johnson SP
J Vasc Interv Radiol; 2005 May; 16(5):751-2. PubMed ID: 15872333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
